Press Release Distribution
Pricing
Customer Support
(800) 998-2927
Login
Log In
All Categories
Business
Entertainment
Health
Finance
Other
Tagged
nsclc
Press Release
Sep 6, 2023
Imagene Announces LungOI, the First AI-Based NSCLC Molecular Panel for Immediate Cancer Biomarker Profiling
Rapid NSCLC Biomarker Test already demonstrated its significant impact and clinical benefits as part of a lung cancer clinical study.
Read More
Press Release
Jul 5, 2021
Scailyte and Lexogen Create a Joint Biomarker Discovery Workflow for Precision Medicine Companies
Read More
Press Release
Jun 22, 2021
Scailyte Announces Michael Brenner, of Harvard Medical School, as an Advisor to Its Board of Directors
Read More
Press Release
Mar 29, 2021
Scailyte and Geninus Announce a Strategic Partnership to Develop a Predictive Assay for Immune-Checkpoint Inhibitors in Non-Small Cell Lung Cancer Patients
Read More
Press Release
Sep 24, 2018
Identifying Spatial Expression Patterns in the Tumor Microenvironment, New Webinar Hosted by Xtalks
Read More
Press Release
Aug 23, 2018
Upcoming Xtalks Webinar: Identifying Novel Targets for Non-Small Cell Lung Cancer - Just How Novel Are They?
Read More
Press Release
Jul 12, 2018
Deep Learning: Automated PD-L1 Tumor Cell Scoring of Resected NSCLC, New Webinar Hosted by Xtalks
PD-L1 expression measured by immunohistochemistry helps identify non-small cell lung cancer (NSCLC) patients that may respond to anti-PD-1/PD-L1 immunotherapies.
Read More
Press Release
Aug 15, 2013
Breast Cancer Drugs May Be Utilized to Treat Lung Cancer
The inhibitors work by aiming two DNA repair systems at the same time, killing cancer cells while evading the healthy cells.
Read More
First
Prev
1
Next
Last
